These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4374418)

  • 21. Malignant hyperpyrexia in Australia and New Zealand.
    King JO; Denborough MA
    Med J Aust; 1973 Mar; 1(11):525-8. PubMed ID: 4699727
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant hyperthermia.
    Rosenberg H
    Hosp Pract (Off Ed); 1985 Mar; 20(3):139, 144-5, 148 passim. PubMed ID: 3932397
    [No Abstract]   [Full Text] [Related]  

  • 23. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.
    Meltzer HY; Hassan SZ; Russo P; Cho HW
    Anesth Analg; 1976; 55(6):797-9. PubMed ID: 1033694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biochemical and electromyographic studies on a family with malignant hyperpyrexia].
    Konno K; Yamashiro H; Hagiwara M; Haseba J; Honda N
    Masui; 1974 Sep; 23(9):854-61. PubMed ID: 4475138
    [No Abstract]   [Full Text] [Related]  

  • 25. [Creatine kinase deficiency of the epidermis in psoriasis vulgaris].
    Rassner G
    Arch Dermatol Forsch; 1973 Mar; 246(2):146-50. PubMed ID: 4699525
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in adenylate deaminase, adenylate kinase, and creatine kinase after prolonged storage of frozen muscle biopsies.
    Fishbein WN
    Muscle Nerve; 1984 May; 7(4):340-1. PubMed ID: 6328294
    [No Abstract]   [Full Text] [Related]  

  • 27. Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome.
    Isaacs H; Heffron JJ
    Br J Anaesth; 1975 Apr; 47(4):475-81. PubMed ID: 124580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preanesthetic diagnosis of malignant hyperthermia.
    Britt BA
    Int Anesthesiol Clin; 1979; 17(4):63-96. PubMed ID: 391722
    [No Abstract]   [Full Text] [Related]  

  • 29. Central core disease associated with elevated creatine phosphokinase levels. Two members of a family known to be susceptible to malignant hyperpyrexia.
    Isaacs H; Barlow MB
    S Afr Med J; 1974 Mar; 48(15):640-2. PubMed ID: 4823722
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple disc gel bands of mitochondrial creatine and adenylate kinases.
    Lapin E; Maker HS; Lehrer GM
    J Neurochem; 1974 Jan; 22(1):11-4. PubMed ID: 4362074
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemiology and inheritance of malignant hyperthermia.
    Kalow W; Britt BA; Chan FY
    Int Anesthesiol Clin; 1979; 17(4):119-39. PubMed ID: 391720
    [No Abstract]   [Full Text] [Related]  

  • 32. Malignant hyperthermia.
    Brown LL; Britt BA
    South Med J; 1974 Jul; 67(7):799-804. PubMed ID: 4834737
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.
    Ellis FR; Clarke IM; Modgill M; Currie S; Harriman DG
    Br Med J; 1975 Aug; 3(5982):511-3. PubMed ID: 1164612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of susceptibility to malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A fatal case of malignant hyperthermia during anaesthesia and a study of the patient's blood relatives.
    Kaukinen S; Stenberg J; Kaukinen L
    Ann Chir Gynaecol Fenn; 1974; 63(3):212-6. PubMed ID: 4411635
    [No Abstract]   [Full Text] [Related]  

  • 36. Levels of adenylate deaminase, adenylate kinase, and creatine kinase in frozen human muscle biopsy specimens relative to type 1/type 2 fiber distribution: evidence for a carrier state of myoadenylate deaminase deficiency.
    Fishbein WN; Armbrustmacher VW; Griffin JL; Davis JI; Foster WD
    Ann Neurol; 1984 Mar; 15(3):271-7. PubMed ID: 6326659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tests of contracture and sensitivity to malignant hyperthermia in 27 patients].
    Krivosic-Horber R; Adnet P; Krivosic I; Theunynck D; Guévart E; Adamantidis M
    Ann Fr Anesth Reanim; 1988; 7(2):132-8. PubMed ID: 3364812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant hyperpyrexia: Investigation of a family after a fatal case.
    Ryan DW; Appleyard TN
    Br J Anaesth; 1975 Sep; 47(9):1001-4. PubMed ID: 1191461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfur specifically inhibits adenylate kinase in assays for creatine kinase.
    Russell PJ; Conner J; Sisson S
    Clin Chem; 1984 Sep; 30(9):1555-7. PubMed ID: 6088119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Be alert for symptoms of malignant hyperthermia.
    Edwards DB
    Dent Stud; 1977 Jun; 55(9):33-4, 39. PubMed ID: 271097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.